US Stock MarketDetailed Quotes

Compass Therapeutics (CMPX)

Watchlist
  • 1.860
  • -0.120-6.06%
Close May 15 16:00 ET
  • 1.869
  • +0.009+0.47%
Post 20:01 ET
334.96MMarket Cap-4.65P/E (TTM)

Compass Therapeutics (CMPX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-30.75%-17.27M
-9.56%-49.14M
-44.66%-13.25M
1.83%-10.85M
-10.02%-11.83M
4.90%-13.21M
-10.43%-44.86M
25.84%-9.16M
-86.61%-11.05M
-6.34%-10.75M
Net income from continuing operations
-10.12%-18.32M
-34.66%-66.49M
-4.54%-15.72M
-36.07%-14.26M
-52.04%-19.88M
-54.19%-16.63M
-16.19%-49.38M
-12.06%-15.03M
-5.17%-10.48M
-15.94%-13.08M
Depreciation and amortization
1.10%368K
-16.03%1.47M
3.06%370K
-20.22%371K
-21.24%367K
-21.38%364K
-7.25%1.75M
-23.29%359K
-0.21%465K
-1.89%466K
Change In working capital
-903.65%-4.19M
321.61%9.18M
-58.72%1.46M
173.59%2.18M
986.36%5.02M
110.04%521K
-42.43%-4.14M
1,917.44%3.54M
-208.04%-2.96M
376.29%462K
-Change in prepaid assets
98.41%-87K
205.33%5.12M
157.88%312K
154.33%4.02M
226.21%6.26M
-485.58%-5.48M
-171.83%-4.86M
-136.89%-539K
-56.55%1.58M
-359.57%-4.96M
-Change in payables and accrued expense
-164.94%-4.06M
129.40%4.43M
-74.48%1.19M
60.20%-1.81M
-120.94%-1.2M
258.96%6.26M
122.82%1.93M
446.21%4.66M
-655.91%-4.54M
479.04%5.75M
-Change in other current liabilities
84.98%-38K
69.68%-369K
93.41%-38K
-840.00%-37K
87.38%-41K
20.94%-253K
-1.25%-1.22M
-86.13%-577K
101.66%5K
-9.06%-325K
Cash from discontinued investing activities
Operating cash flow
-30.75%-17.27M
-9.56%-49.14M
-44.66%-13.25M
1.83%-10.85M
-10.02%-11.83M
4.90%-13.21M
-10.43%-44.86M
25.84%-9.16M
-86.61%-11.05M
-6.34%-10.75M
Investing cash flow
Cash flow from continuing investing activities
231.63%38.43M
-299.49%-93.31M
-121.98%-3.38M
-427.92%-95.16M
-198.10%-6.36M
382.70%11.59M
73.45%46.77M
143.43%15.37M
70.20%29.02M
1,071.96%6.48M
Net PPE purchase and sale
-355.56%-82K
43.18%-25K
--0
84.09%-7K
--0
---18K
-46.67%-44K
--0
-340.00%-44K
--0
Net investment purchase and sale
231.82%38.51M
-299.25%-93.28M
-121.98%-3.38M
-427.40%-95.15M
-198.10%-6.36M
383.14%11.61M
73.42%46.82M
143.08%15.37M
70.36%29.06M
1,088.26%6.48M
Cash from discontinued investing activities
Investing cash flow
231.63%38.43M
-299.49%-93.31M
-121.98%-3.38M
-427.92%-95.16M
-198.10%-6.36M
382.70%11.59M
73.45%46.77M
143.43%15.37M
70.20%29.02M
1,071.96%6.48M
Financing cash flow
Cash flow from continuing financing activities
512.88%3.37M
647.54%129.61M
1,230.85%1.06M
6,468,150.00%129.36M
0
-104.68%-815K
490.73%17.34M
40.51%-94K
-109.52%-2K
-99.97%1K
Net common stock issuance
--3.85M
661.88%138M
--0
--138M
--0
--0
479.43%18.11M
--0
--0
--0
Proceeds from stock option exercised by employees
----
--1.28M
----
----
----
----
--0
--0
--0
--0
Net other financing activities
40.00%-489K
-1,147.10%-9.67M
-125.53%-212K
-431,800.00%-8.64M
--0
-19.85%-815K
-206.32%-775K
40.51%-94K
---2K
--1K
Cash from discontinued financing activities
Financing cash flow
512.88%3.37M
647.54%129.61M
1,230.85%1.06M
6,468,150.00%129.36M
--0
-104.68%-815K
490.73%17.34M
40.51%-94K
-109.52%-2K
-99.97%1K
Net cash flow
Beginning cash position
-29.15%31.21M
81.82%44.05M
25.18%46.78M
20.72%23.42M
73.44%41.62M
79.45%44.05M
-30.67%24.23M
22.82%37.37M
0.65%19.4M
-11.22%23.99M
Current changes in cash
1,107.19%24.53M
-166.68%-12.84M
-354.65%-15.57M
30.01%23.36M
-326.04%-18.19M
-339.53%-2.44M
279.65%19.26M
198.64%6.11M
61.15%17.97M
44.90%-4.27M
End cash Position
33.93%55.74M
-28.22%31.21M
-28.22%31.21M
25.18%46.78M
20.72%23.42M
73.44%41.62M
79.47%43.48M
79.47%43.48M
22.82%37.37M
0.65%19.4M
Free cash flow
-31.19%-17.35M
-9.51%-49.17M
-44.66%-13.25M
2.15%-10.86M
-10.02%-11.83M
4.77%-13.23M
-10.46%-44.9M
25.89%-9.16M
-87.04%-11.1M
-6.22%-10.75M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -30.75%-17.27M-9.56%-49.14M-44.66%-13.25M1.83%-10.85M-10.02%-11.83M4.90%-13.21M-10.43%-44.86M25.84%-9.16M-86.61%-11.05M-6.34%-10.75M
Net income from continuing operations -10.12%-18.32M-34.66%-66.49M-4.54%-15.72M-36.07%-14.26M-52.04%-19.88M-54.19%-16.63M-16.19%-49.38M-12.06%-15.03M-5.17%-10.48M-15.94%-13.08M
Depreciation and amortization 1.10%368K-16.03%1.47M3.06%370K-20.22%371K-21.24%367K-21.38%364K-7.25%1.75M-23.29%359K-0.21%465K-1.89%466K
Change In working capital -903.65%-4.19M321.61%9.18M-58.72%1.46M173.59%2.18M986.36%5.02M110.04%521K-42.43%-4.14M1,917.44%3.54M-208.04%-2.96M376.29%462K
-Change in prepaid assets 98.41%-87K205.33%5.12M157.88%312K154.33%4.02M226.21%6.26M-485.58%-5.48M-171.83%-4.86M-136.89%-539K-56.55%1.58M-359.57%-4.96M
-Change in payables and accrued expense -164.94%-4.06M129.40%4.43M-74.48%1.19M60.20%-1.81M-120.94%-1.2M258.96%6.26M122.82%1.93M446.21%4.66M-655.91%-4.54M479.04%5.75M
-Change in other current liabilities 84.98%-38K69.68%-369K93.41%-38K-840.00%-37K87.38%-41K20.94%-253K-1.25%-1.22M-86.13%-577K101.66%5K-9.06%-325K
Cash from discontinued investing activities
Operating cash flow -30.75%-17.27M-9.56%-49.14M-44.66%-13.25M1.83%-10.85M-10.02%-11.83M4.90%-13.21M-10.43%-44.86M25.84%-9.16M-86.61%-11.05M-6.34%-10.75M
Investing cash flow
Cash flow from continuing investing activities 231.63%38.43M-299.49%-93.31M-121.98%-3.38M-427.92%-95.16M-198.10%-6.36M382.70%11.59M73.45%46.77M143.43%15.37M70.20%29.02M1,071.96%6.48M
Net PPE purchase and sale -355.56%-82K43.18%-25K--084.09%-7K--0---18K-46.67%-44K--0-340.00%-44K--0
Net investment purchase and sale 231.82%38.51M-299.25%-93.28M-121.98%-3.38M-427.40%-95.15M-198.10%-6.36M383.14%11.61M73.42%46.82M143.08%15.37M70.36%29.06M1,088.26%6.48M
Cash from discontinued investing activities
Investing cash flow 231.63%38.43M-299.49%-93.31M-121.98%-3.38M-427.92%-95.16M-198.10%-6.36M382.70%11.59M73.45%46.77M143.43%15.37M70.20%29.02M1,071.96%6.48M
Financing cash flow
Cash flow from continuing financing activities 512.88%3.37M647.54%129.61M1,230.85%1.06M6,468,150.00%129.36M0-104.68%-815K490.73%17.34M40.51%-94K-109.52%-2K-99.97%1K
Net common stock issuance --3.85M661.88%138M--0--138M--0--0479.43%18.11M--0--0--0
Proceeds from stock option exercised by employees ------1.28M------------------0--0--0--0
Net other financing activities 40.00%-489K-1,147.10%-9.67M-125.53%-212K-431,800.00%-8.64M--0-19.85%-815K-206.32%-775K40.51%-94K---2K--1K
Cash from discontinued financing activities
Financing cash flow 512.88%3.37M647.54%129.61M1,230.85%1.06M6,468,150.00%129.36M--0-104.68%-815K490.73%17.34M40.51%-94K-109.52%-2K-99.97%1K
Net cash flow
Beginning cash position -29.15%31.21M81.82%44.05M25.18%46.78M20.72%23.42M73.44%41.62M79.45%44.05M-30.67%24.23M22.82%37.37M0.65%19.4M-11.22%23.99M
Current changes in cash 1,107.19%24.53M-166.68%-12.84M-354.65%-15.57M30.01%23.36M-326.04%-18.19M-339.53%-2.44M279.65%19.26M198.64%6.11M61.15%17.97M44.90%-4.27M
End cash Position 33.93%55.74M-28.22%31.21M-28.22%31.21M25.18%46.78M20.72%23.42M73.44%41.62M79.47%43.48M79.47%43.48M22.82%37.37M0.65%19.4M
Free cash flow -31.19%-17.35M-9.51%-49.17M-44.66%-13.25M2.15%-10.86M-10.02%-11.83M4.77%-13.23M-10.46%-44.9M25.89%-9.16M-87.04%-11.1M-6.22%-10.75M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More